Urgent Care/Mid City
CARE Program
231 North Carrollton Avenue, Suite B, New Orleans, LA 70119
Urgent Care/Mid City CARE Program is an outpatient facility in New Orleans, LA offering substance use treatment. Buprenorphine is used for opioid use disorder. It reports accepting self-payment, TRICARE, Medicaid, Medicare, and private insurance.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Outpatient
- Regular appointments while living at home.
- Outpatient methadone/buprenorphine or naltrexone treatment
- Methadone, buprenorphine, or naltrexone for opioid use, with counseling, without staying overnight.
- Regular outpatient treatment
- Weekly or less frequent appointments while living at home.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Buprenorphine maintenance
- Buprenorphine continued over time to prevent relapse.
- Lofexidine or Clonidine detoxification
- Lofexidine or clonidine to ease withdrawal during detox.
- Maintenance service with medically supervised withdrawal after stabilization
- Medication maintained, then tapered under medical supervision once stable.
- Prescribes buprenorphine
- Prescribes buprenorphine.
Payment
- Accepted
- Cash or self-payment; TRICARE and other federal military insurance; Medicaid; Medicare; Private health insurance; A state-financed health insurance plan other than Medicaid.
Who they serve
- Ages served
- Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
- Sex
- Female; Male.
- Programs for
- Active duty military; Adult men; Adult women; Clients who have experienced intimate partner violence, domestic violence; Clients who have experienced sexual abuse; Clients who have experienced trauma; Clients with HIV or AIDS; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Members of military families; Pregnant/postpartum women; Seniors or older adults; Veterans; Young adults.
- Languages
- Sign language services for the deaf and hard of hearing.
More details this facility reports
- Type of Alcohol Use Disorder Treatment
- Does not treat alcohol use disorder.
- Pharmacotherapies
- Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Medications for pre-exposure to prophylaxis; Nicotine replacement; Non-nicotine smoking/tobacco cessation.
- Treatment Approaches
- Substance use disorder counseling; Telemedicine/telehealth therapy.
- Facility Operation (e.g., Private, Public)
- Private for-profit organization.
- Assessment/Pre-treatment
- Complete medical history/physical exam; Comprehensive substance use assessment; Outreach to persons in the community; Professional interventionist/educational consultant; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
- Testing
- Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; Metabolic syndrome monitoring; STD testing; TB screening; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV).
- Transitional Services
- Aftercare/continuing care; Naloxone and overdose education.
- Education and Counseling Services
- HIV or AIDS education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Hepatitis education, counseling, or support; Individual counseling; Smoking/vaping/tobacco cessation counseling; Substance use disorder education.
- Facility Smoking Policy
- Smoking not permitted.
- Facility Vaping Policy
- Vaping not permitted.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.